REQUEST A DEMO
Total
USD $0.00
Search more companies

PharmaEngine, Inc. (智擎生技制药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PharmaEngine, Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

PharmaEngine, Inc is a biotech pharmaceutical company that specializes in developing new drugs for cancer treatment. PharmaEngine collaborates with global partners to optimize drug development and marketing.

Headquarters
11F, 10 Minsheng E. Road, Sec. 3
Taipei City; Taipei City;

Contact Details: Purchase the PharmaEngine, Inc. (智擎生技制药股份有限公司) report to view the information.

Website: http://www.pharmaengine.com

Basic Information
Total Employees:
Purchase the PharmaEngine, Inc. (智擎生技制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the PharmaEngine, Inc. (智擎生技制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the PharmaEngine, Inc. (智擎生技制药股份有限公司) report to view the information.
Incorporation Date:
August 12, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.75%
Purchase this report to view the information.
15.5%
Purchase this report to view the information.
2.21%
Purchase this report to view the information.
0.99%
Purchase this report to view the information.
0.97%
Subsidiaries
Formosa Pharmaceuticals, Inc.
0.5%
Company Performance
Financial values in the chart are available after PharmaEngine, Inc. (智擎生技制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-2.83%
Total Operating Revenue
-2.86%
Operating Profit
-6.49%
EBITDA
-6.21%
Net Profit/Loss for the Period
-22.9%
Total Assets
20.92%
Total Equity
20.43%
Operating Profit Margin
-1.91%
Net Profit Margin
-10.66%
Return on Equity (ROE)
-3.01%
Debt / Equity
-0.17%
Quick Ratio
-10.21%
Cash Ratio
3.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?